A randomized placebo‐controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia

Abstract

Simethicone and cisapride were significantly better than placebo for symptom control in patients with functional dyspepsia after 2, 4 and 8 weeks of treatment. Simethicone was also superior to the prokinetic cisapride in the first 2 weeks of treatment.